Thursday, April 14, 2011

Table of Contents for PDF

Page 2
SAFER • HEALTHIER • PEOPLE

UPDATES AT:
http://www.cdc.gov/od/science/techtran/TechAvailableForLicensing.htm
Contents
BACTERIAL
Bacillus anthracis
Conjugates of Carbohydrates and Anthrax Protective
Antigen.............................................................................................
......8
Mass Spectrometry-Based Detection Assay for Anthrax Lethal Factor and
Lethal Toxin Activity............................................8
FRET-Based Detection Assay for Anthrax Lethal Toxin Activity in
Serum..............................................................................8
Bordetella pertussis
Bordetella Specific Capture
Reagent....................................................................................................................
.....................8
Diagnosis of Bordetella pertussis (whooping cough) via Nucleic Acid Tests
and Diagnostic Algorithm..................................9
Chlamydia
Real-Time PCR-Based Fluorescent Assay Based on the ompA Gene for Detection
of Chlamydia pneumoniae.......................9
Diagnostic Peptide Sequence Discovered for Chlamydophilia
pneumoniae...............................................................................9
Rapid Method for Molecular Differentiation of Chlamydia Trachomatis
Biovars Strains.........................................................9
Methods and Compositions for the Simultaneous Detection of Multiple
Analytes....................................................................9
Enterobacteriaceae
Oligonucleotide Probes for Detecting Enterobacteriaceae and
Quinolone-Resistant Enterobacteriaceae................................9
Legionella
Real-Time PCR-Based Fluorescent PCR for Detection of Legionella
pneumophila and Legionella spp.................................10
Mycoplasma pneumoniae
Real-time PCR Assay for the Detection of Mycoplasma-Pneumoniae Using a
Cytotoxin Gene Target..................................10
Development of Primers and Probe for Detection of Mycoplasma pneumoniae by
Real-Time PCR.......................................10
Highly Specific Primers and Probe for Detection of Mycoplasma pneumoniae
Infection........................................................10
Internal Controls and Control Probes for Identifying Inhibitors During
Detection Assays of Mycoplasma Pneumoniae and Mycoplasma
Fermentans.......................................................................................
...................................11
Neisseria meningitidis
Invasion Associated Genes from Neisseria meningitidis Serogroup
B.....................................................................................1
1
Nocardia farcinica
Rapid Identification of Nocardia farcinica by a PCR
Assay..............................................................................................
......11
Streptococcus pneumoniae
Functional Epitopes of Streptococcus Pneumoniae PsaA Antigen and Uses
Thereof...............................................................11
Antibiotic Selection Panels for Use in Multiple-Valent Opsonophagocytic
Assay for Streptococcus Pneumoniae.................12
Real-Time PCR Primers and Probe for the Detection of Streptococcus
pneumoniae...............................................................12
Development of Real-time PCR Assay for Detection of Pneumococcal DNA and
Diagnosis of Pneumococcal
Disease.......................................................................................................................
...........................................................12
Peptide from Streptococcus pneumoniae Surface Adhesion A (PsaA) Protein
Associated with Adherence............................12
Pneumococcal Fimbrial Protein
A........................................................................................................................
....................12
Pneumococcal Fimbrial Protein
A.......................................................................................................................
.....................13
Reduction in Staphylococcus epidermidis Viable Biofilm Formation on the
Surface of a Hydrogel Coated Catheter Using S. epidermidis Bacteriophage
PH456...........................................................................
...............................................13
Streptococcus pneumoniae 37-kDa Surface Adhesin A
Protein.............................................................................................
..13
Streptococcus pneumoniae 37-kDa Surface Adhesin A Protein and Nucleic
Acids Coding Therefore....................................13
Recombinant Lipidated PsaA Protein, Methods of Preparation and
Use..................................................................................14
Methods and Compositions for the Simultaneous Detection of Multiple
Analytes..................................................................14
Oligonucleotide Sequences for Amplification of Streptococcus pneumoniae
Gene.................................................................14
Multiple Antigenic Peptides Immunogenic against Streptococcus
pneumoniae.......................................................................14
Epitope Peptides Immunogenic against Streptococcus
pneumoniae.........................................................................................
14
Multiplexed Pneumococcal Serotyping
Assay..............................................................................................
............................15
Streptococcus pyogenes
Real-Time Polymerase Chain Reaction for Identification of Streptococcus
pyogenes.............................................................15
Group A Streptococci
Peptide Vaccines against Group A
Streptococci..........................................................................................................
............15
ENVIRONMENTAL AND AGRICULTURAL
Air Quality
Air Sampler for Collecting Airborne Fungal Spores in a Microcentrifuge
Tube for Molecular Analysis................................15
Page 3
SAFER • HEALTHIER • PEOPLE

UPDATES AT:
http://www.cdc.gov/od/science/techtran/TechAvailableForLicensing.htm
Mold and Fungus
Monoclonal Antibodies against Fungi and Methods for Their
Use..........................................................................................
.15
Pest Control
A New Device for Collecting Resting
Mosquitoes.........................................................................................................
..........15
Compounds for Pest Control and Methods for their
Use..................................................................................................
........16
A Simple Process for Producing Wash-Durable Insecticide Impregnated
Bednets or Other Fabrics.......................................16
Simple, Nondestructive Colorimetric Field Method to Identify and Quantify
Cyanopyrethroid Insecticides..........................16
Synergistic Combinations of Natural Plant Extracts to Control and Repel
Arthropod Pests....................................................17
MISCELLANEOUS AND METHODOLOGIES
Cell Line
Immortalized Endothelial Cell
Line.....................................................................................................................
....................17
Food-borne
A Novel Method Developed to Analyze Saxitoxins in Human
Urine.......................................................................................17
Medical Device
Inactivation of spores and vegetative bacteria on medical devices and
instrumentation using elevated pressure carbon dioxide based
mixtures.......................................................................................
......................................................17
Method and Apparatus for Cough Sound
Analysis.........................................................................................................
..........17
Mixing
Vial............................................................................................................................................
..................................18
Auscultatory Training
System..........................................................................................................................
........................18
Medical Software
Automated Microscopic Image Acquisition, Compositing, and
Display..................................................................................18
Finding Usable Portion of Sigmoid
Curve...............................................................................................................
................18
Methods
Simultaneous Measurement of Multiple Drugs Using Fluorescent Covalent
Microsphere Immunoassay (FCMIA)...............19
Two Optimized Combination Assays To Examine Apoptosis Pathways in Clinical
Samples..................................................19
Primer Extension Enrichment Reaction (PEER)
Protocol..................................................................................................
.......19
Microbial Biofilm
Multicoupon Biofilm CFSTR....................................
..........................................................................................
.....................19
Miscellaneous
Real-time TaqMan® PCR for Human RNaseP
Gene...................................................................................
.............................19
Respirable Particle Sampler for the Collection of Air-Borne Fine and
Ultrafine Particles Directly Into Surrogate Lung Surfactants for
Bioassay...................................................................................
...........................................................19
Artificial Human Mutation Controls for Diagnostic
Testing.............................................................................................
........20
Device to Measure Muscle Contractile/Relaxant and Epithelial Bioelectric
Responses of Perfused, Intact Airways In
Vitro..........................................................................................................
.......................................................................20
Method for Monitoring Local Reaction Associated with
Injections..........................................................
...............................20
Method for Retaining Methylation Pattern in Globally Amplified
DNA..................................................................................20
PCR Exchangeable Template
Reaction....................................................................................................................
................21
Methods for the Prevention and Treatment of Diseases Caused by an
Inflammatory Response...............................................21
Method for Testing Authenticity of Tamiflu
(Oseltamivir)..............................................................................................
.........21
In-Tube Method and Apparatus for Blood Stimulation and Plasma
Collection........................................................................21
Use of Cyanidin-3-Glucoside as an Anti-Tumor
Treatment................................................................................................
.....21
Rapid Method for Detecting Cardiovascular
Disease.....................................................................................................
..........22
Microarray
PNI Microarray and
Uses...............................................................................................................................
..........................22
Integration of Gene Expression Data and Non-Gene
Data.................................................................................................
.......22
Microscope
Improved Compression Algorithm for Images in a Focal
Stack............................................................................................
...22
Improved Image Acquisition for Bright Field
Microscopy................................................................................................
.......22
Organ Culture
Artificial Organ Culture
System........................................................................................................................
.......................23
Polymerase Chain Reaction (PCR)
Photoinduced Electron Transfer (PET) Fluorescent Primer for Nucleic Acid
Amplification...................................................23
Fluorescent Primer for Nucleic Acid
Amplification.....................................................................................................
............23
Page 4
SAFER • HEALTHIER • PEOPLE

UPDATES AT:
http://www.cdc.gov/od/science/techtran/TechAvailableForLicensing.htm
MYCOBACTERIAL
Tuberculosis
Identification of M. Tuberculosis Proteins as Mucosal Vaccine Candidates
Against TB.........................................................23
SecA Gene of Mycobacterium tuberculosis and Related Methods and
Compositions..............................................................23
A Method for the Rapid Diagnosis of Infectious Disease by Detection and
Quantification of Microorganism Induced
Cytokines........................................................................................................
........................................................24
Antibiotics Against Resistant Strains of M. Tuberculosis and Methods for
Producing Them..................................................24
MYCOTIC
Aspergillus
Development and Validation of a Microsphere Luminex-Based Assay for Rapid
Detection of Clinically Relevant Aspergillus
species...................................................................................................
............................................................24
Development of DNA Probes to Identify Aspergillus
Species.............................................................................................
.....24
The Production of Cross-Reactive Monoclonal Antibodies Against Aspergillus
and Penicillium Species..............................24
Detection
Development of DNA Probes to Detect Fungal Pathogens Using a Multi-Analyte
Profiling System......................................25
Histoplasma capsulatum
Development of an Antigen-Capture ELISA Using Rabbit Polyclonal Antibody
to Detect Histoplasma Capsulatum Antigen in Physiological
Specimens......................................................................................
...........................25
Nucleic Acids of the M Antigen Gene of Histoplasma, Isolated and
Recombinant-Produced Antigens, Vaccines and Antibodies, Methods and Kits for
Detecting
Histoplasmosis.........................................................................................25
Rapid and Sensitive Method for Detecting Histoplasma
capsulatum.......................................................................................
25
Stachybotrys chartarum
Monoclonal Antibodies against Fungi and Methods for Their
Use..........................................................................................
.26
PARASITIC
Cryptosporidium parvum
Methods for Detecting Cryptosporidium parvum
Oocysts...................................................................................................
.....26
Reagent and Method for Detecting Cryptosporidium parvum
Oocysts.....................................................................................26
Malaria
Colorimetric Assay for Artemisinin
Derivatives........................................................................................................
..............26
Counterfeit Drug
Buster...............................................................................................................................
............................27
Compositions and Methods for Inhibiting Transmission of
Malaria.......................................................................................
..27
An Improved Recombinant Multivalent Malarial Vaccine Against Plasmodium
Falciparum..................................................27
Recombinant Multivalent Malarial Vaccine against Plasmodium
falciparum..........................................................................27
Taenia solium
Isolation of Diagnostic Glycoproteins to Taenia solium, Immunoblot-Assay
and Method for the Detection of Human
Cysticercosis......................................................................................................
......................................................27
Compositions and Methods for Detecting Adult Taenia
solium............................................................................................
...28
Methods and Compositions for Detecting Larval Taenia solium with a Cloned
Diagnostic Antigen.......................................28
T24 Antigen for Immunodiagnosis of Taenia Solium
Cysticercosis........................................................................................
.28
Trichomonas Vaginalis
Efficacy of Dicationic Compounds Against Trichomonas
Vaginalis........................................................................................2
8
RICKETTSIAL
Ehrlichia
Growing Ehrlichia Species in a Continuous Cell
Line...................................................................................................
...........28
Identification of a New Ehrlichia Species from a Patient Suffering from
Ehrlichiosis.............................................................29
Identification of a
New...............................................................................................................................
..............................29
Identification of a New Ehrlichia Species from a Patient Suffering from
Ehrlichiosis.............................................................29
Identification of a New Ehrlichia Species from a Patient Suffering from
Ehrlichiosis.............................................................29
Use of Human Immortalized Endothelial Cells to Isolate and Propagate
Ehrlichia chaffeensis and Ehrlichia canis...............29
Use of Human Immortalized Endothelial Cells to Isolate and Propagate
Ehrlichia chaffeensis and Ehrlichia canis...............30
Novel Granulocytic Ehrlichia Genes and Uses
Thereof....................................................................................................
.......30
SOFTWARE
Family Healthware - Assessment, Classification, and Intervention
Guide................................................................................
30
Spatial Random Sampling Using GPS Receivers and Handheld
Computers............................................................................30
GSA Rent Data Download Tririga Component (Tririga 8i Software Add-on
Component)......................................................31
Page 5
SAFER • HEALTHIER • PEOPLE

UPDATES AT:
http://www.cdc.gov/od/science/techtran/TechAvailableForLicensing.htm
SEXUALLY TRANSMITTED DISEASES
Chlamydia
Methods and Compositions for the Simultaneous Detection of Multiple
Analytes..................................................................31
Syphilis
Attachment of Cardiolipin to Protein for Development of Non-Treponemal
Antibody Assays...............................................31
DNA Polymerase from Treponema
pallidum................................................................................................................
...........31
Compositions and Methods for Detecting Syphilis Using Synthetic
Antigens.........................................................................32
Compositions and Methods for Detecting Treponema
pallidum.............................................................................................
..32
Immunological Immobilization of Cardiolipin Antigen to a Solid
Support..............................................................................32
Herpes Virus
Novel Baculovirus Expression Vectors and Recombinant Antigens for
Detecting Type-Specific Antibodies to Herpes Simplex
Virus......................................................................................................
.....................................................32
Novel Baculovirus Expression Vectors and Recombinant Antigens for
Detecting Type-Specific Antibodies to Herpes Simplex
Virus.....................................................................................................
......................................................32
VETERINARY
Cat-Scratch Disease
Methods and Compositions for Diagnosing Cat-Scratch Disease and Bacillary
Angiomatosis Caused by Bartonella
henselae..............................................................................................................
................................................33
Compositions for Diagnosing Bartonella henselae and Bartonella quintana
Infection............................................................33
Nucleic Acids Specific for Bartonella
quintana........................................................................................................
...............33
Nucleic Acids of Bartonella henselae and Methods and Compositions for
Diagnosing Bartonella henselae and Bartonella quintana
Infection......................
.........................................................................................................................33
Nucleic Acids of Bartonella henselae and Compositions for Diagnosing
Bartonella henselae and Bartonella quintana
Infection.......................................................................................................
..........................................................34
Composition to Protect a Mammal against Bartonella henselae
Infection...............................................................................34
Canine Influenza
Mouse Monoclonal Antibodies Specific for the H3 Hemagglutinin of Canine
Influenza Virus...............................................34
Chlamydiosis
Genotyping of Chlamydophila psittaci using Real-time PCR and High
Resolution Melt analysis...........................................34
Diagnostic Methods
Use of Biotin to Conjugate Antibodies in Serum Samples to Enable Detection
of Antigen-specific Antibodies in Species for Which Species-specific
Secondary Antibody Conjugates are Commercially
Unavailable.................................34
Rabies
Development of Vaccines for the Oral Immunization of Mongoose (Herpestes
auropunctatus) against Rabies......................35
Raccoon Poxvirus as Gene Expression and Vaccine Vector for Genes of Rabies
Virus and Other Organisms........................35
VIRAL
Adenovirus
Real-Time TaqMan® PCR for Human Adenovirus Type
4.....................................................................................................
.35
Astrovirus
Nucleic Acids Encoding Human Astrovirus Serotype 2 and Uses
Thereof..............................................................................35
Bocavirus
Real Time TaqMan PCR Assays and Positive Control for Human
Bocavirus..........................................................................35
Ebola
Vaccination Method to Protect Against Ebola
Virus.....................................................................................................
...........36
Immunization for Ebola Virus
Infection................................................................................................................
..................36
Mutant Form of Ebola Virus - Pseudotyped Retrovirus
Vectors...........................................................................................
....36
Recombinant Infectious Molecular Clone of a Simian Foamy Virus (SFV)
Expressing a Truncated form of the Ebola Virus Glycoprotein
Gene............................................................................................
................................................36
Enterovirus
Detection and Identification of Nonpolio
Enteroviruses................................................................................................
...........36
Typing of Human Nonpolio
Enteroviruses................................................................................................................
..............37
Sensitive, Semi-nested PCR-Amplification of VP1 Sequences for Direct
Identification of Enteroviruses Serotypes from Orical
Specimens.............................................................................................
............................................................37
Flavivirus
Nucleic Acid Vaccines for Prevention of Flavivirus
Infection..........................................................................................
........37
Nucleic Acid Vaccines for Prevention of Flavivirus
Infection..........................................................................................
........37
Page 6
SAFER • HEALTHIER • PEOPLE

UPDATES AT:
http://www.cdc.gov/od/science/techtran/TechAvailableForLicensing.htm
Hantavirus
Nucleic Acid of a Novel Hantavirus and Reagents for Detection and
Prevention of Infection.................................................38
Nucleic Acids of a Novel Hantavirus and Reagents for Detection and
Prevention of Infection...............................................38
Black Creek Canal Hantavirus and Related
Methods......................................................................................................
..........38
Bayou Hantavirus and Related
Methods..................................................................................................................
................38
Hepatitis
Systemically Delivered Nano-immunolipoplex Vaccine for Prevention/Therapy
of Hepatitis C Virus (HCV).......................39
Antigenically Reactive Regions of the Hepatitis A Virus
Polyprotein...................................................................................
...39
Neutralizing Immunogenic Hepatitis E Virus
Polypeptides...............................................................................................
.......39
Synthetic Peptides Immunoreactive with Hepatitis A Virus
Antibodies...................................................................................
39
Mosaic Protein and Restriction Endonuclease Assisted Ligation Method for
Making the Same..............................................39
Mosaic Protein and Restriction Endonuclease Assisted Ligation Method for
Making the Same..............................................40
Antigenic Epitopes and Mosaic Polypeptides of Hepatitis C Virus
Protein..............................................................................4
0
HIV
Development of a Rapid Assay for the Extraction, Amplification and
Detection of Human Immunodeficiency Virus Nucleic
Acid........................................................................................................
.......................................................40
Detection of HIV-1 p24 Antigen and HIV Specific Antibodies Using a Rapid,
Paramagnetic Lateral Flow Assay................40
Utilization of loop-mediated isothermal amplification (LAMP) for the
Detection of HIV-1 Infection....................................40
Soluable Human Dendritic Cell Specific ICAM-3 Grabbing Non-Integrin
(shDC-SIGN).......................................................41
A Simple Assay for Detecting Recent HIV-1 Infection and Estimating
Incidence...................................................................41
Development of a Chimeric Recombinant HIV-1 Envelope Protein Derived from
Immunodominant Region (IDR) of Multiple
Subtypes.......................................................................................................
.....................................................41
Method and Kit for Detecting Resistance to Antiviral
Drugs............................................................................................
.......41
Method and Kit for Detecting Resistance to Antiviral
Drugs............................................................................................
.......41
Methods and Compositions for Inhibition of Viral
Replication..........................................................................................
......41
Methods and Reagents for Molecular Detection of HIV-1
Groups..........................................................................................
.42
Cytotoxic T Cell (CTL) Epitopes of HIV (Subtype E): Reagents for Research,
Drug Studies and HIV Vaccines...................42
Development of a HIV-1 Multi-Clade, Multivalent (HIV1MCMV) Recombinant
Vaccine Construct....................................42
Development of a Rapid HIV Diagnostic Assay for Diagnosis and Detection of
Recent and Long Term HIV-1
Infection...................................................................................................................
.............................................................42
Development and Characterization of Large Volume Panels of Plasma, PMBC,
and DBS from HIV Strains from West
Africa...............................................................................................................
............................................................43
Multiple Antigenic Peptide Assay for Detection of HIV or SIV Type
Retroviruses.................................................................43
RAB9 and Uses Thereof Related to Infectious
Disease...................................................................................................
.........43
Simple, Rapid, and Sensitive Real-Time PCR Methods for Detecting Drug
Resistance in Human Immunodeficiency Viruses
(HIV).........................................................................................................
...............................43
Recombinant Infectious Clone of Simian Foamy Virus (SFV) Expressing HIV-1
gp 120 for Vaccine Purposes....................44
Prevention of Rectal HIV
Transmission..................................................................................................................
.................44
Human Papillomavirus
Human Papillomavirus (HPV) Variant Assignment by
Pyrosequencing..................................................................................44
Influenza
Simultaneous Detection and Quantification of Influenza Proteins in Complex
Matrices.........................................................44
Mouse Monoclonal Antibodies Specific for the H5 Hemagglutinin of Avian
Influenza Virus................................................44
Enhancing Disease Resistance against RNA Viral
Infections.............................................................................................
......45
High Growth Reassortant Avian Influenza Virus with an Avirulent
Hemagglutinin................................................................45
Preparation and Use of Recombinant Influenza A Virus M2 Constructs and
Vaccines............................................................45
Primer and Probes for Detection and Discrimination of Types and Subtypes
of Influenza Viruses by Real-Time
RT-PCR................................................................................................................
................................................................45
Lymphotropic
A Novel Simian T-cell Lymphotopic Virus, Designated
STLV-5............................................................................................
46
Novel Human T-Cell Lymphotropic Virus, Designated
HTLV-3.............................................................................................4
6
Measles
Measles Virus Specific Antibody Detection Using Recombinant Measles
Proteins.................................................................46
Norovirus
A Monoclonal Antibody (McAb-NoV) Which is Cross-Reactive to at Least 2
Genogroup I Strains and 8 Genogroup II Strains of Noravirus in the Family
Caliciviridae...................................................................
..........................46
Orthopoxvirus
Rapid Protein-Based Diagnostic Test System that Can Detect Exposure to or
Presence of Orthopoxviruses..........................46
Page 7
SAFER • HEALTHIER • PEOPLE

UPDATES AT:
http://www.cdc.gov/od/science/techtran/TechAvailableForLicensing.htm
Monoclonal Antibodies Specific for Variola
Virus......................................................................................................
.............47
Diagnostic Assay for Orthopoxviruses Other than
Variola...............................................................................................
........47
Diagnostic Assay for
Cowpox...........................................................................................................................
.......................47
Therapeutic Treatment of Poxvirus
Infections..........................................................................................................
...............47
Parechovirus
Three Parechovirus Diagnostic Assays Utilizing Real Time Taqman or
Seminested RT-PCR................................................47
Poliovirus
Modulation of Poliovirus Replicative Fitness by Deoptimization of
Synonymous Codons......................................................48
Rabies
Simplified Method for Whole Genome Sequencing of
Lyssaviruses........................................................................................4
8
Vector for Recombinant Poxvirus Expressing Rabies Virus
Glycoprotein...............................................................................48
Method of Sequencing Rabies Whole Genome and its Application in Vaccine
Development.................................................48
Retrovirus
Methods for Sensitive Detection of Reverse
Transcriptase..............................................................................................
.........49
Methods for Sensitive Detection of Reverse
Transcriptase..............................................................................................
.........49
Method and Kit for Detecting Resistance to Antiviral
Drugs............................................................................................
.......49
Compositions, Methods and Devices for Detection of Retroviral
Infection..............................................................................4
9
Methods and Devices for Detection of Xenogenic Graft
Persistence......................................................................................
..49
Respiratory Syncytial Virus
Real-Time TaqMan® RT-PCR for Human Metapneumovirus, Human Parainfluenza
Virus 1; 2; and 3, and Human Respiratory Syncytial
Virus..................................................................................................
................................................50
Compositions and Methods for Modulating RSV Infection and
Immunity..............................................................................50
CD40 Ligand Adjuvant for Respiratory Syncytial
Virus..................................................................................................
........50
Macroaggregated Albumin-Polyethylenimine (MAA-PEI) Lung-Targeted Delivery
of RSV DNA Vaccines.........................50
Rhinovirus
Real-time TaqMan RT-PCR Assays for Human
Rhinovirus...................................................................................................
..50
Rift Valley Fever Virus
Development of Rift Valley Fever Virus Vaccines Utilizing Reverse
Genetics.......................................................................51
Development of a Pan-Rift Valley Fever Virus Real-Time Quantitative RT-PCR
Diagnostic Assay......................................51
Rotavirus
Novel Method to Inactivate
Retrovirus.................................................................................................................
...................51
Rotavirus Strain
G9P11................................................................................................................................
............................51
New Parenteral Human Rotavirus Vaccine Strains CDC-6, CDC-7, CDC-8, and
CDC-9.......................................................51
New Human Rotavirus Vaccine Strains - CDC-66 and
CDC-81..............................................................................................5
2
SARS
Novel Coronavirus Isolated from
Humans................................................................................................................
...............52
West Nile Virus
Humanized Murine Monoclonal Antibodies for Arboviral
Serodiagnosis................................................................................52
Duplex Microsphere Based Immunoassay for Detection of Anti-West Nile Virus
and Anti-St. Louis Encephalitis Virus, Immunoglobin M. Antibodies, and
Development of
Software...................................................................................52

1 comment:

malaria microscope said...
This comment has been removed by a blog administrator.